Changes in bone mass and metabolism after surgery for primary hyperparathyroidism

Area of Science:

• Endocrinology
• Bone Metabolism
• Surgical Outcomes

Background:

• Primary hyperparathyroidism (pHPT) often leads to reduced bone mass, with partial reversibility after parathyroidectomy.
• The skeletal benefits of surgery in mild, asymptomatic pHPT remain uncertain, particularly at specific bone sites.

Purpose of the Study:

• To assess the site-specific and overall skeletal benefits of parathyroidectomy in patients with mild primary hyperparathyroidism.
• To investigate the relationship between preoperative parathyroid hormone (PTH) levels and bone mass changes after surgery.

Main Methods:

• Cross-sectional and longitudinal study designs were employed.
• Bone mineral density was measured at the lumbar spine, hip, and whole body using DXA, and at the os calcis using ultrasound.
• Biochemical markers (PTH, osteocalcin) and urinary pyridinium cross-links were monitored pre- and post-surgery.

Main Results:

• Baseline bone mass at the spine and hip correlated inversely with serum PTH concentration and parathyroid gland weight.
• Six months post-surgery, bone mass increased significantly at the femoral neck, greater trochanter, whole body, and os calcis, but not the lumbar spine or Ward's area.
• Postoperative PTH, osteocalcin, and urinary cross-links decreased significantly, with bone mineral gains proportional to baseline PTH levels.

Conclusions:

• In pHPT, preoperative bone loss and postoperative bone gain are proportional to initial PTH levels.
• Mild pHPT may not cause significant bone loss at critical fracture sites (spine, hip).
• The overall skeletal benefits of parathyroidectomy in mild pHPT are likely minimal.